1 s, tuberculosis, chronic herpes simplex, and disseminated histoplasmosis).

2 h serious infectious complications including disseminated histoplasmosis.

3 TNF-alpha therapy are at risk for developing disseminated histoplasmosis.

4 patients resulting in two (3.3%) deaths from disseminated histoplasmosis and a herpes virus infection

5                         We present a case of disseminated histoplasmosis, complicated by retroperiton

6                                        Since disseminated histoplasmosis has emerged as a difficult c

7 ned the immunomodulatory effects of IL-12 on disseminated histoplasmosis in immunodeficient SCID mice

8    We report on three patients who developed disseminated histoplasmosis on therapy with TNF-alpha in

9 emic, where delayed diagnosis of progressive disseminated histoplasmosis (PDH) results in high mortal

10                 Sera from four patients with disseminated histoplasmosis showed falls in antigen leve

11 s been previously shown in a murine model of disseminated histoplasmosis that IL-12, IFN-gamma, and T

12  from three patients with acute pulmonary or disseminated histoplasmosis were also positive.